CBD Global Sciences EBIT margin
Quel est le EBIT margin de CBD Global Sciences?
Le EBIT margin de CBD Global Sciences Inc. est -277.81%
Quelle est la définition de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin des entreprises dans Health Care secteur sur OTC par rapport à CBD Global Sciences
Que fait CBD Global Sciences?
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
Entreprises avec ebit margin similaire à CBD Global Sciences
- PowerHouse plc a EBIT margin de -281.73%
- DQ Entertainment (International) a EBIT margin de -281.18%
- DQ Entertainment (International) a EBIT margin de -281.18%
- Kisses from Italy a EBIT margin de -279.60%
- Cymabay Therapeutics Inc a EBIT margin de -278.14%
- Marker Therapeutics a EBIT margin de -278.12%
- CBD Global Sciences a EBIT margin de -277.81%
- Kisses from Italy a EBIT margin de -276.96%
- UK Oil & Gas PLC a EBIT margin de -276.60%
- Anworth Mortgage Asset a EBIT margin de -276.32%
- 102570 a EBIT margin de -276.10%
- PlantX Life a EBIT margin de -275.64%
- Starlite Components a EBIT margin de -275.42%